Huahai Pharmaceutical (600521.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 1.06 billion yuan, a year-on-year increase of 178.61%.

Zhitong Finance APP News, Huahai Pharmaceutical (600521.SH) disclosed its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 7.425 billion yuan, a year-on-year increase of 15.86%; net profit attributable to the parent company was 1.06 billion yuan, a year-on-year increase of 178.61%; net profit after deducting non-recurring gains and losses was 702 million yuan, a year-on-year increase of 159.96%; basic earnings per share were 0.71 yuan.